NPI-001 is a proprietary, GMP-grade formulation of N-acetylcysteine amide (NACA) tablets being developed to target oxidative stress associated with diseases such as retinitis pigmentosa. Preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback